Calcipotriol/Nicotinamide

卡泊三醇/尼克酰胺

Report date: 2022/01/24 09:15:36

Base Information

Drug NameCalcipotriol/Nicotinamide
Drug Alias Name尼克酰胺卡泊三醇Nicotinamide/Calcipotriene尼克酰胺/卡泊三醇Calcipotriol and NicotinamideCalcipotriene and Nicotinamide +[9] 
ClassificationSmall molecules
Mechanisms of ActionVitamin D receptor agonistsMitogen-activated protein kinase inhibitors
TargetsVitamin D receptorMitogen-activated protein kinase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CalcipotriolNicotinamide
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNextgen-Biomed
China Registration ClassN/A

Develop Information

Active CompaniesNextgen-Biomed
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A